Today's medtech developers seem intent on getting to actual use -“first-in-human” (FIH) - as soon as possible. But, what motivates the race to FIH? Why is it so important and meaningful to quickly achieve that first actual use case of a new medical device? Furthermore, are the motivations guided in a way that aligns with safety and efficacy?
Due to critical differences in economic conditions — and unique unmet needs in the Indian market — what works well in the West may not succeed in India. While India’s medical devices and equipment market is growing strongly, a variety of factors specific to that market are impacting the performance of each product type.
Although final publication of the new Medical Device Regulations (MDR) and In Vitro Diagnostic Regulations (IVDR) is unlikely to occur before early 2017, companies now can map out transition and compliance plans with more certainty. Here, we’ll discuss the crucial considerations that firms should weigh in the meantime.
The world is still reeling from the UK’s decision to exit the European Union (EU) – known universally as Brexit. While it is still early, and speculation grossly outweighs measurable outcomes, there are several areas where the UK’s medical device market is vulnerable to an EU exit.
Radio frequency (RF) ablation uses RF energy to ablate or destroy unwanted tissues. When delivered via a catheter, it offers a minimally invasive treatment for a wide variety of conditions, including atrial fibrillation (AF). These systems typically include a peristaltic pump to provide cooling or temperature control, and this pump must be able to produce and control the high pressures (up to 130 psi) required in this application.
Shifts in healthcare have essentially changed suppliers’ role in the industry – especially when it comes to infection prevention. And, they’ve greatly impacted how both providers and suppliers think about the use of antimicrobials.
Labels often are an afterthought, because they don’t directly affect the capabilities of a medical device. However, they certainly affect the functionality of the device and users’ ability to effectively utilize all of its features. Consider these factors — and their importance — as you design your medical device overlay or inventory stickers.
In the race to bring innovative products to market, ensuring a seamless transition from design to manufacturing is critical. Yet, in today’s marketplace, design and manufacturing engineers alike are faced with many new challenges.
Looking at the rising trend towards self-administration therapies, injectable drug delivery devices such as pen injectors, autoinjectors and needle free injectors show a significant growth potential in the near future.
Following the successful listing of its lighting business on the Euronext Amsterdam Stock Exchange in May, Royal Philips can now focus squarely on its HealthTech business, according to its chief executive.
Zimmer Biomet announced its plans to leverage the company’s years of consulting experience with its cultivated portfolio of technologies and analytical tools to create an “end-to-end” suite of clinical services called Signature Solutions. The intent of the service is to drive greater efficiency and improve patient outcomes in hospitals while working with the hospitals’ existing infrastructure.
Taking inspiration from bacteria, a team of Swiss scientists has developed a platform for developing microrobots that can be customized for various medical indications, such as delivering drugs or performing delicate surgical operations, including unblocking clogged arteries. These tiny robots shapeshift in response to heat and can be remotely controlled using electromagnetic fields.
GE Healthcare posted a strong second quarter, and the conglomerate's top executives believe that favorable markets and real opportunities for growth will keep the unit’s performance sustainable.
Medtronic wants to generate $40 billion in free-cash-flow (FCF) by 2021, senior leadership said during a recent Investor Day event in New York City. The company’s strategies for future growth include therapy innovation, globalization, and a leadership position in value-based healthcare.
Johnson & Johnson's DePuy Synthes is expanding its collaboration with Belgian 3D printing company Materialise to offer patient-specific titanium craniomaxillofacial (CMF) implants under the DePuy Synthes TRUMATCH portfolio.
Medtronic plc recently announced the global launch of VariLoc Locking Compression Plate System in China and other select countries.
Polylactic acid, or PLA, is a biodegradable polymer commonly used to make a variety of products from disposable cups to medical implants to drug delivery systems.